Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
12.87
-0.27 (-2.05%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.94 billion as of October 2, 2026. Its market cap has increased by 23.99% in one year.
Market Cap
1.94B
Enterprise Value
1.97B
1-Year Change
23.99%
Ranking
Category
Stock Price
$12.87
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.94B, an increase of 643.16%. That is a compound annual growth rate of 64.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.94B | 29.76% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.07B |
| Vericel | 2.06B |
| Trevi Therapeutics | 2.04B |
| Maravai LifeSciences Holdings | 1.99B |
| Palvella Therapeutics | 1.99B |
| UroGen Pharma | 1.99B |
| Agios Pharmaceuticals | 1.99B |
| Nuvation Bio | 1.97B |